A detailed history of Redpoint Investment Management Pty LTD transactions in Astrazeneca PLC stock. As of the latest transaction made, Redpoint Investment Management Pty LTD holds 3,939 shares of AZN stock, worth $253,120. This represents 0.03% of its overall portfolio holdings.

Number of Shares
3,939
Previous 13,110 69.95%
Holding current value
$253,120
Previous $866,000 75.06%
% of portfolio
0.03%
Previous 0.1%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 14, 2022

SELL
$53.02 - $135.75 $486,246 - $1.24 Million
-9,171 Reduced 69.95%
3,939 $216,000
Q3 2021

Nov 12, 2021

BUY
$55.56 - $60.79 $728,391 - $796,956
13,110 New
13,110 $787,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $199B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Redpoint Investment Management Pty LTD Portfolio

Follow Redpoint Investment Management Pty LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Redpoint Investment Management Pty LTD, based on Form 13F filings with the SEC.

News

Stay updated on Redpoint Investment Management Pty LTD with notifications on news.